Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

C18:1 Ceramide (d18:1/18:1(9Z))

🥰Excellent
Catalog No. T35808Cas No. 5966-28-9
Alias Cer(d18:1/18:1(9Z)), C18:1-Ceramide

C18:1 Ceramide (d18:1/18:1(9Z)) is a ceramide, and C18:1-Ceramide levels are elevated in overweight and insulin-resistant mice and cattle, as well as in plasma and ovarian tissue of patients with advanced ovarian cancer.

C18:1 Ceramide (d18:1/18:1(9Z))

C18:1 Ceramide (d18:1/18:1(9Z))

🥰Excellent
Purity: 99.96%
Catalog No. T35808Alias Cer(d18:1/18:1(9Z)), C18:1-CeramideCas No. 5966-28-9
C18:1 Ceramide (d18:1/18:1(9Z)) is a ceramide, and C18:1-Ceramide levels are elevated in overweight and insulin-resistant mice and cattle, as well as in plasma and ovarian tissue of patients with advanced ovarian cancer.
Pack SizePriceAvailabilityQuantity
1 mg$36In Stock
5 mg$80In Stock
10 mg$128In Stock
25 mg$257In Stock
50 mg$410In Stock
100 mg$655In Stock
200 mg$990In Stock
Add to Cart
Add to Quotation
Bulk & Custom
Questions
View More
Select Batch
Purity:99.96%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
C18:1 Ceramide (d18:1/18:1(9Z)) is a ceramide, and C18:1-Ceramide levels are elevated in overweight and insulin-resistant mice and cattle, as well as in plasma and ovarian tissue of patients with advanced ovarian cancer.
In vitro
Exogenous C18:1-Ceramide (5 μM, 24 h) significantly increased the survival of mouse primary retinal ganglion cells (RGCs) and reduced apoptosis induced by oxygen-glucose deprivation/reperfusion (OGD/R)[1].
In vivo
Intravitreal injection of C18:1-Ceramide (1 μL, 10 μM) in a mouse optic nerve ischemia model improved structural integrity and reduced RGC apoptosis, supporting its neuroprotective potential in ischemic retinal injury[1].
AliasCer(d18:1/18:1(9Z)), C18:1-Ceramide
Chemical Properties
Molecular Weight563.94
FormulaC36H69NO3
Cas No.5966-28-9
Smiles[C@@H](NC(CCCCCCC/C=C\CCCCCCCC)=O)([C@@H](/C=C/CCCCCCCCCCCCC)O)CO
Relative Density.no data available
Storage & Solubility Information
Storagekeep away from direct sunlight | store at 4°C | Shipping with blue ice./Shipping at ambient temperature.
Solubility Information
DMF: 80 mg/mL (141.86 mM), Sonication is recommended.
Chloroform: 4 mg/mL (7.09 mM), Sonication is recommended.
Solution Preparation Table
Chloroform/DMF
1mg5mg10mg50mg
1 mM1.7732 mL8.8662 mL17.7324 mL88.6619 mL
5 mM0.3546 mL1.7732 mL3.5465 mL17.7324 mL
DMF
1mg5mg10mg50mg
10 mM0.1773 mL0.8866 mL1.7732 mL8.8662 mL
20 mM0.0887 mL0.4433 mL0.8866 mL4.4331 mL
50 mM0.0355 mL0.1773 mL0.3546 mL1.7732 mL
100 mM0.0177 mL0.0887 mL0.1773 mL0.8866 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Sci Citations

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy C18:1 Ceramide (d18:1/18:1(9Z)) | purchase C18:1 Ceramide (d18:1/18:1(9Z)) | C18:1 Ceramide (d18:1/18:1(9Z)) cost | order C18:1 Ceramide (d18:1/18:1(9Z)) | C18:1 Ceramide (d18:1/18:1(9Z)) chemical structure | C18:1 Ceramide (d18:1/18:1(9Z)) in vivo | C18:1 Ceramide (d18:1/18:1(9Z)) in vitro | C18:1 Ceramide (d18:1/18:1(9Z)) formula | C18:1 Ceramide (d18:1/18:1(9Z)) molecular weight